Comparing the glucuronidation capacity of the feline liver with substrate-specific glucuronidation in dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 37, Issue 1, 2014, Pages 18-24

  Van Beusekom, C D ^a   Fink Gremmels, J ^a   Schrickx, J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHOL; ESTRADIOL; ESTRADIOL 17 GLUCURONIDE; HYMECROMONE; MORPHINE; MORPHINE 3 GLUCURONIDE;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; FELIDAE; FEMALE; GLUCURONIDATION; LIVER METABOLISM; LIVER MICROSOME; MALE; MICHAELIS MENTEN KINETICS; NONHUMAN; PRIORITY JOURNAL; PSEUDOGENE;

CANIS FAMILIARIS; FELIDAE;

ANIMALS; CATS; DOGS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; MALE; MICROSOMES, LIVER; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY;

EID: 84892368540     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/jvp.12067     Document Type: Article

References (47)

1. Bosma, P.J., Seppen, J., Goldhoorn, B., Bakker, C., Oude Elferink, R.P., Chowdhury, J.R., Chowdhury, N.R. & Jansen, P.L. (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. Journal of Biological Chemistry, 269, 17960-17964.
2. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
3. Capel, I.D., French, M.R., Millburn, P., Smith, R.L. & Williams, R.T. (1972a) The fate of (14C)phenol in various species. Xenobiotica, 2, 25-34.
4. Capel, I.D., French, M.R., Millburn, P., Smith, R.L. & Williams, R.T. (1972b) Species variations in the metabolism of phenol. Biochemical Journal, 127, 25P-26P.
5. Capel, I.D., Millburn, P. & Williams, R.T. (1974) The conjugation of 1- and 2-naphthols and other phenols in the cat and pig. Xenobiotica, 4, 601-615.
6. Chauret, N., Gauthier, A., Martin, J. & Nicoll-Griffith, D.A. (1997) In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metabolism and Disposition, 25, 1130-1136.
7. Coffman, B.L., Rios, G.R., King, C.D. & Tephly, T.R. (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metabolism and Disposition, 25, 1-4.
8. Court, M.H. (2005) Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases. Methods in Enzymology, 400, 104-116.
9. Court, M.H. & Greenblatt, D.J. (1997) Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes. Biochemical Pharmacology, 53, 1041-1047.
10. Court, M.H. & Greenblatt, D.J. (2000) Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms. Pharmacogenetics, 10, 355-369.
11. Dong, D., Ako, R., Hu, M. & Wu, B. (2012) Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes. Xenobiotica, 42, 808-820.
12. Ebner, T. & Burchell, B. (1993) Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metabolism and Disposition, 21, 50-55.
13. Ebner, T., Schanzle, G., Weber, W., Sent, U. & Elliott, J. (2013) In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: a comparison with other species. Journal of Veterinary Pharmacology and Therapeutics, 36, 154-160.
14. Elliott, H.W. (1976) Metabolism of lorazepam. British Journal of Anaesthesia, 48, 1017-1023.
15. Furlan, V., Demirdjian, S., Bourdon, O., Magdalou, J. & Taburet, A.M. (1999) Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers. Journal of Pharmacology and Experimental Therapeutics, 289, 1169-1175.
16. Gall, W.E., Zawada, G., Mojarrabi, B., Tephly, T.R., Green, M.D., Coffman, B.L., Mackenzie, P.I. & Radominska-Pandya, A. (1999) Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. Journal of Steroid Biochemistry and Molecular Biology, 70, 101-108.
17. Green, M.D. & Tephly, T.R. (1996) Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metabolism and Disposition, 24, 356-363.
18. Green, M.D., King, C.D., Mojarrabi, B., Mackenzie, P.I. & Tephly, T.R. (1998) Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metabolism and Disposition, 26, 507-512.
19. Harbourt, D.E., Fallon, J.K., Ito, S., Baba, T., Ritter, J.K., Glish, G.L. & Smith, P.C. (2012) Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry. Analytical Chemistry, 84, 98-105.
20. Hashizume, T., Xu, Y., Mohutsky, M.A., Alberts, J., Hadden, C., Kalhorn, T.F., Isoherranen, N., Shuhart, M.C. & Thummel, K.E. (2008) Identification of human UDP-glucuronosyltransferases catalyzing hepatic 1alpha, 25-dihydroxyvitamin D3 conjugation. Biochemical Pharmacology, 75, 1240-1250.
21. Jin, C., Miners, J.O., Lillywhite, K.J. & Mackenzie, P.I. (1993) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. Journal of Pharmacology and Experimental Therapeutics, 264, 475-479.
22. Kiang, T.K., Ensom, M.H. & Chang, T.K. (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacology & therapeutics, 106, 97-132.
23. King, C., Finley, B. & Franklin, R. (2000) The glucuronidation of morphine by dog liver microsomes: identification of morphine-6-O-glucuronide. Drug Metabolism and Disposition, 28, 661-663.
24. Kubota, T., Lewis, B.C., Elliot, D.J., Mackenzie, P.I. & Miners, J.O. (2007) Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4. Molecular Pharmacology, 72, 1054-1062.
25. Mackenzie, P.I., Walter Bock, K., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., Miners, J.O., Owens, I.S. & Nebert, D.W. (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenetics and Genomics, 15, 677-685.
26. Magdalou, J., Chajes, V., Lafaurie, C. & Siest, G. (1990) Glucuronidation of 2-arylpropionic acids pirprofen, flurbiprofen, and ibuprofen by liver microsomes. Drug Metabolism and Disposition, 18, 692-697.
27. Mano, Y., Usui, T. & Kamimura, H. (2004) Effects of beta-estradiol and propofol on the 4-methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9. Biopharmaceutics & Drug Disposition, 25, 339-344.
28. Martinez, M.N., Antonovic, L., Court, M., Dacasto, M., Fink-Gremmels, J., Kukanich, B., Locuson, C., Mealey, K., Myers, M.J. & Trepanier, L. (2013) Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics. Drug metabolism reviews, 45, 218-230.
29. Miners, J.O. & Mackenzie, P.I. (1991) Drug glucuronidation in humans. Pharmacology & therapeutics, 51, 347-369.
30. Miners, J.O., Lillywhite, K.J. & Birkett, D.J. (1988) In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation. Biochemical Pharmacology, 37, 2839-2845.
31. Miners, J.O., Smith, P.A., Sorich, M.J., McKinnon, R.A. & Mackenzie, P.I. (2004) Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches. Annual Review of Pharmacology and Toxicology, 44, 1-25.
32. Ohno, S. & Nakajin, S. (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metabolism and Disposition, 37, 32-40.
33. Pekanmaki, K. & Salmi, H.A. (1961) The absorption and excretion of phenolphthalein and its glucuronide by the cat. Acta Pharmacologica et Toxicologica, 18, 133-140.
34. Radominska-Pandya, A., Czernik, P.J., Little, J.M., Battaglia, E. & Mackenzie, P.I. (1999) Structural and functional studies of UDP-glucuronosyltransferases. Drug Metabolism Reviews, 31, 817-899.
35. Rowland, A., Miners, J.O. & Mackenzie, P.I. (2013) The UDP-Glucuronosyltransferases: their role in drug metabolism and detoxification. The international journal of biochemistry & cell biology, 45, 1121-1132.
36. Ruelius, H.W. (1978) Comparative metabolism of lorazepam in man and four animal species. The Journal of Clinical Psychiatry, 39, 11-15.
37. Rutten, A.A., Falke, H.E., Catsburg, J.F., Topp, R., Blaauboer, B.J., van Holsteijn, I., Doorn, L. & van Leeuwen, F.X. (1987) Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Reinvestigation of assay conditions. Archives of Toxicology, 61, 27-33.
38. Schillings, R.T., Sisenwine, S.F., Schwartz, M.H. & Ruelius, H.W. (1975) Lorazepam: glucuronide formation in the cat. Drug Metabolism and Disposition, 3, 85-88.
39. Senafi, S.B., Clarke, D.J. & Burchell, B. (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochemical Journal, 303(Pt 1), 233-240.
40. Soars, M.G., Petullo, D.M., Eckstein, J.A., Kasper, S.C. & Wrighton, S.A. (2004) An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. Drug Metabolism and Disposition, 32, 140-148.
41. Stone, A.N., Mackenzie, P.I., Galetin, A., Houston, J.B. & Miners, J.O. (2003) Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7. Drug Metabolism and Disposition, 31, 1086-1089.
42. Taylor, P.M., Robertson, S.A., Dixon, M.J., Ruprah, M., Sear, J.W., Lascelles, B.D., Waters, C. & Bloomfield, M. (2001) Morphine, pethidine and buprenorphine disposition in the cat. Journal of Veterinary Pharmacology and Therapeutics, 24, 391-398.
43. Tukey, R.H. & Strassburg, C.P. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual Review of Pharmacology and Toxicology, 40, 581-616.
44. Uchaipichat, V., Mackenzie, P.I., Guo, X.H., Gardner-Stephen, D., Galetin, A., Houston, J.B. & Miners, J.O. (2004) Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metabolism and Disposition, 32, 413-423.
45. Watkins, J.B., 3rd & Klaassen, C.D. (1986) Xenobiotic biotransformation in livestock: comparison to other species commonly used in toxicity testing. Journal of animal science, 63, 933-942.
46. Yamada, A., Maeda, K., Ishiguro, N., Tsuda, Y., Igarashi, T., Ebner, T., Roth, W., Ikushiro, S. & Sugiyama, Y. (2011) The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers. Pharmacogenetics and Genomics, 21, 523-530.
47. Yeh, S.Y., Chernov, H.I. & Woods, L.A. (1971) Metabolism of morphine by cats. Journal of Pharmaceutical Sciences, 60, 469-471.